ARIX Arix Bioscience

Notice of Results & Investor Presentation

Arix Bioscience PLC (ARIX)
Notice of Results & Investor Presentation

03-Aug-2022 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

 

Arix Bioscience plc

 

Notice of Results & Investor Presentation

 

LONDON, 3 August 2022: Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a global venture capital company focused on investing in breakthrough biotechnology companies, will announce its results for the six months ended 30 June 2022 on Wednesday 10 August 2022.

 

Analyst Briefing: 9:00am, Wednesday 10 August

 

Management will host a virtual analyst presentation followed by a Q&A session at 9:00am BST on Wednesday 10 August. Analysts wishing to join should register their interest by contacting .

 

Investor Presentation: 2:00pm, Wednesday 10 August

 

Management will be hosting a live presentation and Q&A session via the online platform, Investor Meet Company, at 2:00pm BST on Wednesday 10 August.

 

The presentation is open to analysts and all existing and potential shareholders. Questions can be submitted pre-event via the 'Investor Meet Company' dashboard up until 9:00 a.m. on Wednesday 10 August or at any time during the live presentation. Investors can sign up to Investor Meet Company for free via: 

 

Investors who already follow Arix on the Investor Meet Company platform will automatically receive an invitation to the event.

 

[ENDS]

 

Enquiries

For more information on Arix, please contact:

 

Arix Bioscience plc

+44 (0)20 7290 1050

ir

 

Powerscourt Group

Sarah MacLeod, Ibrahim Khalil, Nick Johnson

+44 (0)20 7250 1446

 

About Arix Bioscience plc

Arix Bioscience plc is a global venture capital company focused on investing in breakthrough biotechnology companies around cutting-edge advances in life sciences.

 

We collaborate with exceptional entrepreneurs and provide the capital, expertise, and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.

 

 
ISIN: GB00BD045071
Category Code: NOR
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.: 178861
EQS News ID: 1411893

 
End of Announcement EQS News Service

fncls.ssp?fn=show_t_gif&application_id=1411893&application_name=news&site_id=research_pool
EN
03/08/2022

Underlying

ARIXArix Bioscience

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Arix Bioscience

ECK ECKOH
TYM Tertiary Minera... ... (+9)

Hybridan Small Cap Feast - 12 Feb 24

12th February 2024 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment obj...

ECK ECKOH
TYM TERTIARY MINERALS PLC
GOOD GOOD ENERGY GROUP
VAL VALIRX
DCTA DIRECTA PLUS
ARIX ARIX BIOSCIENCE
JNEO JOURNEO PLC
POLB POOLBEG PHARMA PLC
ECR ECR MINERALS PLC
02/12/24 February 12, 2024 1 EN
 PRESS RELEASE
Free
ARIX ARIX BIOSCIENCE

Scheme Effective

Arix Bioscience PLC (ARIX) Scheme Effective 12-Feb-2024 / 12:00 GMT/BST THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR IMMEDIATE RELEASE Legal En...

February 12, 2024 1 EN
 PRESS RELEASE
Free
ARIX ARIX BIOSCIENCE

Suspension of Trading in Shares

Arix Bioscience PLC (ARIX) Suspension of Trading in Shares 12-Feb-2024 / 07:00 GMT/BST THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR IMMEDIATE RE...

February 12, 2024 1 EN
 PRESS RELEASE
Free
ARIX ARIX BIOSCIENCE

Transaction Update

Arix Bioscience PLC (ARIX) Transaction Update 07-Feb-2024 / 11:30 GMT/BST THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR IMMEDIATE RELEASE Legal ...

February 7, 2024 1 EN
 PRESS RELEASE
Free
ARIX ARIX BIOSCIENCE

Results of First General Meeting

Arix Bioscience PLC (ARIX) Results of First General Meeting 29-Jan-2024 / 12:15 GMT/BST THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR IMMEDIATE R...

January 29, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch